Unsurprisingly, low distance from CD3+CD8+ T cells to tumor cells correlated with improved OS and PFS (Supplementary Figure S4C), although not significantly, which may be due to the sample size and highly heterogeneous TME. This evidence concerns the gene CD8A and neoplasm.